Literature DB >> 10527806

T cell receptor BV gene rearrangements in the spinal cords and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.

M A Panzara1, E Gussoni, A B Begovich, R S Murray, Y Q Zang, S H Appel, L Steinman, J Zhang.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal disorder whose etiology and pathogenesis remain unknown. Recent studies, however, have demonstrated the presence of inflammatory infiltrates within ALS spinal cord and suggested the possibility of an immune-mediated process in motor neuron degeneration. We have analyzed the diversity of T-cells in the spinal cord in ALS. Reverse transcriptase polymerase chain reaction (RT-PCR) with variable (V) region sequence specific oligonucleotide primers was used to amplify T-cell receptor (TCR)BV transcripts from spinal cords obtained at autopsy from patients with ALS, patients who died without inflammatory disease of the central nervous system, brains from patients with ALS, and brains from patients who died with inflammatory CNS disease. Sequencing was then performed on the amplified transcripts. An overall increase in the level of TCRBV 2 transcripts was detected in ALS specimens when compared to controls. This result was independent of the HLA genotype of the individual. Furthermore, enrichment of TCRBV2-positive T cells could be demonstrated in cerebrospinal fluid derived from patients with ALS, using PCR analysis and a T cell stimulation assay with toxic shock syndrome toxin-1 (TSST-1), a Vbeta2-specific superantigen. Our results suggest that an immunological process involving the specific expansion of Vbeta2 TCR-positive T-cells may be important in the pathogenesis of ALS. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10527806     DOI: 10.1006/nbdi.1999.0252

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  5 in total

Review 1.  Activated microglia: the silent executioner in neurodegenerative disease?

Authors:  S H Appel; E P Simpson
Journal:  Curr Neurol Neurosci Rep       Date:  2001-07       Impact factor: 5.081

Review 2.  The role of immune-mediated alterations and disorders in ALS disease.

Authors:  João Rodrigues Lima-Junior; David Sulzer; Cecilia S Lindestam Arlehamn; Alessandro Sette
Journal:  Hum Immunol       Date:  2021-02-12       Impact factor: 2.850

Review 3.  Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis.

Authors:  Melissa Bowerman; Thierry Vincent; Frédérique Scamps; Florence E Perrin; William Camu; Cédric Raoul
Journal:  Front Cell Neurosci       Date:  2013-11-19       Impact factor: 5.505

Review 4.  Autoimmune Aspects of Neurodegenerative and Psychiatric Diseases: A Template for Innovative Therapy.

Authors:  Peter de Haan; Hans C Klein; Bert A 't Hart
Journal:  Front Psychiatry       Date:  2017-04-04       Impact factor: 4.157

Review 5.  Protective and Regenerative Roles of T Cells in Central Nervous System Disorders.

Authors:  Frances L Evans; Marie Dittmer; Alerie G de la Fuente; Denise C Fitzgerald
Journal:  Front Immunol       Date:  2019-09-12       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.